SEC Form 4 · accession 0001280776-17-000084
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Faheem Hasnain
Director
Period of report
Sep 5, 2017
Accepted (ET)
Sep 6, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.15 | Sep 5, 2017 | A | 15,222 | A | — | Sep 4, 2027 | Common Stock | 15,222 | 15,222 | D |
Explanation of responses
- F1Subject to the reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through the vesting date, 100% of the shares will vest upon the earlier of the one (1) year anniversary from September 5, 2017 or the day prior to the Company's 2018 annual meeting of stockholders.